Immunotherapies for the Treatment of Uveal Melanoma—History and Future
Sign Up to like & getrecommendations! Published in 2019 at "Cancers"
DOI: 10.3390/cancers11081048
Abstract: Background: Uveal melanoma is the most common primary intraocular malignancy among adults. It is, nevertheless, a rare disease, with an incidence of approximately one case per 100,000 individuals per year in Europe. Approximately half of… read more here.
Keywords: melanoma history; treatment uveal; treatment; immunotherapies treatment ... See more keywords